Cost-Effectiveness Analysis of PCSK9 Inhibitors for the Treatment of Heterozygous Familial Hypercholesterolemia
Class of 2017 Abstract === Objectives: To determine the cost-effectiveness of proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors with high-intensity statins compared to high-intensity statins alone for the treatment of heterozygous familial hypercholesterolemia (HeFH). Methods: A Markov mo...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
The University of Arizona.
2017
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10150/624203 http://arizona.openrepository.com/arizona/handle/10150/624203 |